This brand name is authorized in Estonia, Japan, Lithuania, South Africa
The drug FROBEN contains one active pharmaceutical ingredient (API):
1
Flurbiprofen
UNII 5GRO578KLP - FLURBIPROFEN
|
Flurbiprofen is a propionic acid derivative NSAID which acts through inhibition of prostaglandin synthesis. In humans flurbiprofen has potent analgesic, antipyretic and anti-inflammatory properties. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
FROBEN Coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A01AD11 | Various | A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1669776, 1669787 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1149011D1032, 1149011F1076 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1075073 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): K/3.1/4, K/3.1/5, Q/3.1/260, Q/3.1/338, V/3.1/90 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.